Phase 1 and 2 Clinical Studies of the STING Agonist Ulevostinag With and Without Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors or Lymphomas
1. 请及时下载文件确认是否正确, 系统将在 2025-07-01 12:42:58 删除文件
2. 如若文件有误请驳回应助文件, 求助状态即回到求助中
3. 如若文件正确请及时点击确认, 若超过时后系统自动默认为已完结
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1158/1078-0432.ccr-24-3630
其他信息:
出版社: American Association for Cancer Research (AACR)
作者: Kevin J. Harrington; Stephane Champiat; Joshua D. Brody; Byoung Chul Cho; Emanuela Romano; Talia Golan; John R. Hyngstrom; James Strauss; David Y. Oh; Aron Popovtzer; Carlos Gomez-Roca; Ruth Perets; Sung-Bae Kim; Deborah J. Wong; Steven F. Powell; Anuradha Khilnani; Thomas Jemielita; Qing Zhao; Runchen Zhao; Matthew Ingham
全文下载地址: https://aacrjournals.org/clincancerres/article-pdf/doi/10.1158/1078-0432.CCR-24-3630/3621236/ccr-24-3630.pdf
